Ansun BioPharma
PrivateLast Round
Series B
Oct 14, 2019
Total Funding Raised
$215M
Company Overview
Ansun BioPharma is a biopharmaceutical company that develops host-directed recombinant protein therapeutics to treat severe viral respiratory infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ansun BioPharma Comparables
Compare Ansun BioPharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Altesa BioSciences | 78% | |
| Synairgen plc | 77% | |
| Cocrystal Pharma Inc | 73% | |
Ansun BioPharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 14, 2019 | ||||
| Series A | May 14, 2018 | ||||
| Grant | Sep 1, 2006 |
Ansun BioPharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Matrix | Series B, Series A |
| Korea Investment Partners | Series B |
| Bencao Capital | Series B, Series A |
| NIH RADx | Grant |
| Next Capital | Series B |
| Junson Capital | Series B |
| LYFE Capital | Series B, Series A |
Ansun BioPharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ansun BioPharma's valuation, stock price, and market status.